...
首页> 外文期刊>Pediatric Cardiology >Percutaneous Stent Placement in Children Weighing Less Than 10 Kilograms
【24h】

Percutaneous Stent Placement in Children Weighing Less Than 10 Kilograms

机译:体重不足10公斤的儿童经皮支架置入

获取原文
获取原文并翻译 | 示例

摘要

The objectives of this study were to evaluate the safety, efficacy, and outcomes of palliative percutaneous stent placement in infants with congenital heart disease (CHD). There is interest in improving outcomes of infants with CHD through interventional/surgical collaboration. Small, high-risk patients may benefit from delayed open operations, and endovascular stents may provide a means to defer surgery to more advantageous times in select infants. Patients weighing ≤10 kg in whom stent placement was attempted during 2003–2006 were identified. Diagnoses, indications, angiographic and hemodynamic data, complications, and outcomes were reviewed. Seventeen stents were successfully placed in 15 patients. The mean age was 10.21 months; the mean weight was 6.08 kg. Indications were branch pulmonary artery stenosis, coarctation, total anomalous pulmonary venous return with obstructed venous egress, right ventricle-pulmonary artery conduit, and shunt stenosis. Premounted Palmaz Genesis and Driver Mx stents were used. Average vessel diameter increased from 3.65 to 6.72 mm (p < 0.001). The pressure gradient fell from 24 to 15 mm Hg (p < 0.01). Two stents migrated. One was recaptured and implanted at the target site and one implanted away from the target site. None needed surgical intervention. Mean follow-up was 270 days. Five patients have had additional surgery; seven patients underwent 10 additional stent dilations. There was no procedural-related mortality. Five patients (33%) died during the follow-up period, none attributable to the stent placement. We conclude that stent placement can be successfully accomplished in select, small, high-risk patients. A collaborative interventional/surgical paradigm is important to ensure that the risk-benefit ratio is properly evaluated during the patient selection.
机译:这项研究的目的是评估先天性心脏病(CHD)婴儿姑息性经皮支架置入的安全性,疗效和结果。有兴趣通过干预/手术合作改善冠心病婴儿的结局。小型高危患者可能会因延迟开放手术而受益,而血管内支架可能会提供一种将手术推迟至某些婴儿更有利时机的方法。确定了在2003年至2006年期间尝试放置支架的体重≤10 kg的患者。回顾了诊断,适应症,血管造影和血流动力学数据,并发症和结局。在15例患者中成功放置了17个支架。平均年龄为10.21个月;平均体重为6.08公斤。适应症为分支肺动脉狭窄,缩窄,完全异常的肺静脉回流,静脉出口受阻,右心室-肺动脉导管和分流狭窄。使用预安装的Palmaz Genesis和Driver Mx支架。平均血管直径从3.65毫米增加到6.72毫米(p <0.001)。压力梯度从24毫米汞柱降至15毫米汞柱(p <0.01)。迁移了两个支架。一枚被重新捕获并植入目标部位,另一枚远离目标部位植入。不需要手术干预。平均随访时间为270天。五名患者接受了额外的手术; 7名患者接受了10次额外的支架扩张术。没有与程序相关的死亡率。五名患者(33%)在随访期间死亡,无一例归因于支架置入。我们得出结论,在选定的小型,高风险患者中可以成功完成支架置入。协作式干预/手术范例对于确保在患者选择期间正确评估风险收益比非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号